Business
Adia Med Unveils a Fresh Facelift: New Website by ZenChange Marketing Spotlights Cutting-Edge Regenerative Medicine Studies
Adia Med Unveils a Fresh Facelift: New Website by ZenChange Marketing Spotlights Cutting-Edge Regenerative Medicine Studies.
About this update from Adia Nutrition, Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Adia Med Unveils a Fresh Facelift: New Website by ZenChange Marketing Spotlights Cutting-Edge Regenerative Medicine Studies\r\n \r\n \r\n\r\n\r\nAdia Med Unveils a Fresh Facelift: New Website by ZenChange Marketing Spotlights Cutting-Edge Regenerative Medicine Studies\r\n\r\n\r\n\r\nNewsfile Corp.\r\n\r\n\r\nNewsfile Corp\r\n\r\n\r\nOrlando, Florida--(Newsfile Corp. - March 9, 2026) - Adia Nutrition's (OTCQB: ADIA) subsidiary, Adia Med, has launched a complete digital refresh of its online presence. Through a strategic partnership with ZenChange Marketing, Adia Med has relaunched its website with a modern, streamlined design focused on transparency, accessibility, and clear information about its investigational studies. The update makes it easier for families, researchers, and healthcare professionals to explore the organization's dedication to scientific integrity and participant safety.\r\n\r\n\r\nTo view an enhanced version of this graphic, please visit:\r\nhttps://images.newsfilecorp.com/files/10520/287751_adia.jpg\r\nThe redesigned website, now managed and optimized by ZenChange Marketing, serves as the primary hub for Adia Med's current and upcoming clinical research efforts. Visitors will find intuitive navigation, detailed study summaries, eligibility criteria, enrollment information, educational content on stem cell therapies, and timely updates. ZenChange Marketing has also taken over management of all Adia Nutrition and Adia Med social media channels to deliver consistent, engaging, and informative content across platforms.\r\nA central feature of the refreshed site is the dedicated section for Adia Med's Autism Stem Cell Clinical Study (NCT07304440), where recruitment is currently active. This investigational 24-month study examines the potential of AdiaVita, umbilical cord blood-derived stem cells and exosomes, combined with glutathione therapy in children ages 3-12 with Autism Spectrum Disorder (ASD). The protocol includes three monthly AdiaVita stem cell IV infusions, with a one-time participation cost of $12,000 covering all three IVs and study-related procedures.\r\nAdia Med has significantly reduced the price of the study to make it as affordable as possible while still covering essential overhead costs. The organization has selected this patient-pay model without grants or government funding...